News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avid Bioservices, Inc. to Present at IBC's Preclinical Scale Bioprocessing Conference November 1-3, 2010


10/25/2010 8:54:58 AM

TUSTIN, CA and BOSTON, MA--(Marketwire - October 25, 2010) - Avid Bioservices, Inc., a leading provider of integrated commercial and clinical manufacturing services and a subsidiary of Peregrine Pharmaceuticals, Inc., announced that company representatives will present at IBC's Preclinical Scale Bioprocessing Conference, Strategies to Improve the Speed, Quality and Cost of Early Bioprocess Development, on Monday, November 1, 2010 at 5:00 pm EDT in Boston, MA. A pioneer in the early adoption of single-use bioreactors (S.U.B.), Avid will highlight data comparing its S.U.B. (Thermo Scientific HyClone S.U.B.) and its traditional stainless steel bioreactors at the company's cGMP manufacturing facility in Orange County, CA.

"As we help clients accelerate the drug development process and time to market, our early adoption of single-use bioreactors has been critical in achieving efficiencies and flexibility in antibody biomanufacturing," said Richard Richieri, senior director, client technical services, of Avid Bioservices. "The consistent data we have seen from using our traditional bioreactor and our S.U.B. allow us to offer flexible and scalable biomanufacturing services to our clients."

Avid's presentation is titled "Large Scale Cell Culture Production Using Single Use Technology, Comparison of the 1,000L S.U.B. vs. 1,000L Stainless Steel Bioreactor" and will take place in the Olympia room of the Hyatt Harborside Hotel at 5:00 pm EDT on Monday, November 1, 2010.

About IBC's Early Development Forums
IBC's Preclinical Scale Bioprocessing Conference will take place November 1-3, 2010 at the Hyatt Harborside Hotel in Boston, MA. IBC's Early Development forums provide a venue for research, development and regulatory scientists to support early-stage process and analytical development. The 7th conference in this series, Preclinical Scale Bioprocessing seeks to provide strategies to navigate the critical early stage of bioprocess development to conserve resources, optimize product quality and support a successful IND filing. For additional information on this conference, please visit http://www.ibclifesciences.com/preclinical/overview.xml.

About Thermo Scientific HyClone S.U.B.
The Thermo Scientific HyClone S.U.B. consists of a reusable stainless steel outer support container and S.U.B. BioProcess Container (BPC®) that integrates with existing bioreactor control systems, providing the advantages of single-use bioprocessing without having to install a complete new bioreactor system. The retrofit product replaces the stainless steel bioreactor vessel in existing bioreactor systems, making it a flexible, rapid and economic option to increase bioreactor capacity.

About Avid Bioservices
Avid Bioservices provides a comprehensive range of high quality cGMP manufacturing services for the biotechnology and biopharmaceutical industries to support manufacturing of cGMP commercial and clinical products. With over 10 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cell banking, stability testing, clinical and commercial product manufacturing and purification, bulk packaging, final product filling and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell line optimization, analytical methods development and product characterization. For more information about Avid, please visit www.avidbio.com.

About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus infection with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc., which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.


Contact:
Amy Figueroa
Peregrine Pharmaceuticals
(800) 987-8256
Email Contact


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES